Myasthenia gravis: understanding treatment patterns and direct medical costs in the Czech Republic.

ABSTRACT:

Background

Myasthenia gravis (MG) is a rare autoimmune disorder with significant clinical implications, including life-threatening myasthenic crises and exacerbations. Understanding real-world treatment patterns, especially associated direct medical costs, is essential for the effective management of healthcare delivery.

Methods

We conducted a descriptive cohort study using health administrative claims data from the Czech Republic covering more than 1,500 prevalent MG patients. Data were analysed for healthcare resource utilization, medication costs, and hospitalization rates related to MG and its complications.

Results

Acetylcholine inhibitors and corticosteroids were widely prescribed, with 91.1% and 75.2% of patients receiving them at least once, respectively. Immu

SUBMITTER: Donin G 

PROVIDER: S-EPMC11662583 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature